PRIMARY CARE VISITS ARE THE KEY FACTOR IN ENSURING HIGHER VACCINATION RATES IN POST-LIVER TRANSPLANT PATIENTS. A SINGLE CENTER STUDY

Document Type

Conference Proceeding

Publication Date

11-2020

Publication Title

Hepatology

Abstract

Background: Liver transplant recipients are at an increased risk for life threatening vaccine preventable disease. If vaccines are not given pre-transplant, major societal guidelines recommend they are given in the post-transplant period. This retrospective study evaluates vaccination rates in our institution and potential areas for improvement. Methods: A retrospective study of patients transplanted between 1/2015-1/2018 at our institution was performed. Relevant data collected included patient demographics, travel distance to transplant center, primary care provider (PCP) location and PCP and transplant clinic visits. Vaccination status and eligibility for influenza (IV), pneumococcus (PV), Hepatitis-A (HAV) and B (HBV), Tdap and Td vaccines (TdV) were obtained through our electronic medical records and the Michigan Care Improvement Registry. Statistics were calculated using analysis of variance (ANOVA), chi-square, Fisher’s exact test and Wilcoxon Rank Sum Test. Results: 406 patients met our inclusion criteria with 83.0% (336) Caucasians, 10.8% (44 ) African-Americans, 3.7% (15) Hispanics with overall mean age of 59. PCP visitation post-transplant was significantly associated with vaccination of IV (62.9% vs 47.2% p=0.007), HAV (66.7% vs 45.5% p= 0.003), HBV (60.0% vs 50.1% p=0.391), PV (64.6% vs 39.6% p

Volume

2020

Issue

72

First Page

836

Last Page

836

This document is currently not available here.

Share

COinS